The table below shows ABBOTT LABORATORIES's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$1.31B
$1.42B
$1.02B
$1.14B
$2.06B
$2.64B
Capital expenditure
$399.00M
$484.00M
$398.00M
$380.00M
$321.00M
$397.00M
Investing cash flow
-$20.32B
-$470.00M
-$425.00M
-$462.00M
-$360.00M
-$422.00M
Dividends paid
$1.10B
$1.03B
$957.00M
$890.00M
ABT operating cash flow (10-K history)
ABBOTT LABORATORIES reported operating cash flow of $9.57B for fiscal year 2025. That is up 11.8% from $8.56B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $3.20B (FY 2016) to $9.57B. Figures come from the company's audited annual reports as filed with the SEC.
